Cost-Effectiveness Analysis of Siltuximab for Australian Public Investment in the Rare Condition Idiopathic Multicentric Castleman Disease

por Shupo, Francis, Abrams, Keith R., Ademi, Zanfina, Wayi-Wayi, Grace, Zibelnik, Natasa, Kirchmann, Matt, Rutherford, Carolyn, Makarounas-Kirchmann, Kelly
Publicado 2023